Vericel Corporation (VCEL)
NASDAQ: VCEL · IEX Real-Time Price · USD
50.11
-1.12 (-2.19%)
At close: Jul 19, 2024, 4:00 PM
50.09
-0.02 (-0.04%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Vericel Revenue
Vericel had revenue of $207.78M in the twelve months ending March 31, 2024, with 22.72% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $51.28M with 25.02% year-over-year growth. In the year 2023, Vericel had annual revenue of $197.52M with 20.17% growth.
Revenue (ttm)
$207.78M
Revenue Growth
+22.72%
P/S Ratio
11.72
Revenue / Employee
$661,720
Employees
314
Market Cap
2.44B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 197.52M | 33.15M | 20.17% |
Dec 31, 2022 | 164.37M | 8.18M | 5.24% |
Dec 31, 2021 | 156.18M | 32.01M | 25.77% |
Dec 31, 2020 | 124.18M | 6.33M | 5.37% |
Dec 31, 2019 | 117.85M | 26.99M | 29.71% |
Dec 31, 2018 | 90.86M | 26.93M | 42.13% |
Dec 31, 2017 | 63.92M | 9.54M | 17.54% |
Dec 31, 2016 | 54.38M | 3.22M | 6.28% |
Dec 31, 2015 | 51.17M | 22.37M | 77.69% |
Dec 31, 2014 | 28.80M | 28.78M | 151,457.89% |
Dec 31, 2013 | 19.00K | -2.00K | -9.52% |
Dec 31, 2012 | 21.00K | 3.00K | 16.67% |
Dec 31, 2011 | 18.00K | -71.00K | -79.78% |
Jun 30, 2010 | 89.00K | -93.00K | -51.10% |
Jun 30, 2009 | 182.00K | -340.00K | -65.13% |
Jun 30, 2008 | 522.00K | -163.00K | -23.80% |
Jun 30, 2007 | 685.00K | -178.00K | -20.63% |
Jun 30, 2006 | 863.00K | -46.00K | -5.06% |
Jun 30, 2005 | 909.00K | -393.00K | -30.18% |
Jun 30, 2004 | 1.30M | 458.00K | 54.27% |
Jun 30, 2003 | 844.00K | -33.00K | -3.76% |
Jun 30, 2002 | 877.00K | -22.00K | -2.45% |
Jun 30, 2001 | 899.00K | -251.00K | -21.83% |
Jun 30, 2000 | 1.15M | 269.00K | 30.53% |
Jun 30, 1999 | 881.00K | 632.00K | 253.82% |
Jun 30, 1998 | 249.00K | -129.00K | -34.13% |
Jun 30, 1997 | 378.00K | -1.23M | -76.51% |
Jun 30, 1996 | 1.61M | 1.09M | 211.22% |
Jun 30, 1995 | 517.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Ardent Health Partners | 5.53B |
Integra LifeSciences Holdings | 1.53B |
Astrana Health | 1.45B |
PTC Therapeutics | 927.56M |
Myriad Genetics | 774.20M |
UFP Technologies | 407.33M |
Certara | 360.69M |
Intellia Therapeutics | 52.60M |
VCEL News
- 3 days ago - Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024 - GlobeNewsWire
- 5 weeks ago - Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024 - GlobeNewsWire
- 2 months ago - Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024 - GlobeNewsWire
- 2 months ago - Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance - GlobeNewsWire
- 3 months ago - Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024 - GlobeNewsWire
- 5 months ago - Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance - GlobeNewsWire
- 5 months ago - Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024 - GlobeNewsWire
- 5 months ago - Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire